Inozyme Pharma, Inc. (INZY)
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.
Address
321 SUMMER STREET
BOSTON, MA 02210
Founded
2015
Number of Employees
59
Website
http://www.inozyme.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)